Increasing cell biomass in Saccharomyces cerevisiae increases recombinant protein yield: the use of a respiratory strain as a microbial cell factory
© Ferndahl et al; licensee BioMed Central Ltd. 2010
Received: 10 March 2010
Accepted: 17 June 2010
Published: 17 June 2010
Recombinant protein production is universally employed as a solution to obtain the milligram to gram quantities of a given protein required for applications as diverse as structural genomics and biopharmaceutical manufacture. Yeast is a well-established recombinant host cell for these purposes. In this study we wanted to investigate whether our respiratory Saccharomyces cerevisiae strain, TM6*, could be used to enhance the productivity of recombinant proteins over that obtained from corresponding wild type, respiro-fermentative strains when cultured under the same laboratory conditions.
Here we demonstrate at least a doubling in productivity over wild-type strains for three recombinant membrane proteins and one recombinant soluble protein produced in TM6* cells. In all cases, this was attributed to the improved biomass properties of the strain. The yield profile across the growth curve was also more stable than in a wild-type strain, and was not further improved by lowering culture temperatures. This has the added benefit that improved yields can be attained rapidly at the yeast's optimal growth conditions. Importantly, improved productivity could not be reproduced in wild-type strains by culturing them under glucose fed-batch conditions: despite having achieved very similar biomass yields to those achieved by TM6* cultures, the total volumetric yields were not concomitantly increased. Furthermore, the productivity of TM6* was unaffected by growing cultures in the presence of ethanol. These findings support the unique properties of TM6* as a microbial cell factory.
The accumulation of biomass in yeast cell factories is not necessarily correlated with a proportional increase in the functional yield of the recombinant protein being produced. The respiratory S. cerevisiae strain reported here is therefore a useful addition to the matrix of production hosts currently available as its improved biomass properties do lead to increased volumetric yields without the need to resort to complex control or cultivation schemes. This is anticipated to be of particular value in the production of challenging targets such as membrane proteins.
The development of recombinant protein production systems that can be applied to a wide range of targets is a key area of research. This is particularly true for the production of membrane proteins, which are high value targets in the drug discovery pipeline, and which cannot yet be produced in high yields in a predictable manner. Grisshammer and Tate first addressed these issues in 1995 in their review of the challenges of producing recombinant membrane proteins . While more recent articles have individually covered the use of bacteria [2–5], yeasts , insect cells , mammalian cells  and cell-free systems  as production hosts [10, 11], it is apparent that generic solutions are still not forthcoming and that the way forward should be through a rationalization of the science of protein production [12–14].
Yeast species, especially Pichia pastoris and S. cerevisiae [6, 11, 15, 16] have already been identified as one of the most important components of a matrix of protein production hosts , and have contributed a substantial number of recombinant eukaryotic membrane proteins that have enabled high resolution structure determination [17–20]. We and others [21–23] have recently started to take a more systematic approach  to optimise S. cerevisiae as a host cell for recombinant protein production. In general, a sequenced genome and well-understood expression vectors with a range of promoters and expression tags make this yeast species an attractive and flexible option. While the P. pastoris system has a much smaller set of vectors available and a less-well-established molecular biology, it can be cultured to very high densities  potentially producing large quantities of the protein of interest. Recently we examined factors, including pre-induction cellular biomass, affecting the total yield of recombinant green fluorescent protein (GFP) in P. pastoris , and noted the benefits of this as a strategy to improve productivity. While this approach is generally accepted to be a useful way to boost the yields of soluble proteins, it is well established that the accumulation of biomass does not necessarily lead to a correlated increase in membrane protein yield  and in the case of G protein-coupled receptors (GPCRs), specific activity is often lower . Indeed, it has been noted that higher cell densities can generate cellular stresses leading to modifications in membrane composition  and that this modified environment influences the activity of recombinant proteins. Consequently, medium cell density fermentation procedures for GPCR expression in P. pastoris have been suggested to be preferable to ones where biomass yields are maximised .
Here we examined a respiratory strain of S. cerevisiae, TM6*, which generates substantially higher biomass yields than wild-type at the expense of ethanol formation [28, 29]. We asked whether this strain could be used as a tool to generate improved volumetric yields of functional proteins, especially membrane proteins. Since this strain has an engineered phenotype, we anticipated that this might mitigate against the cellular stress associated with biomass accumulation in wild-type strains. In the TM6* strain, glucose uptake is solely dependent on a chimeric hexose transporter mediating reduced sugar uptake: the strain was generated by integrating the gene encoding the chimeric hexose transporter, Tm6*, into the genome of a hexose transporter null yeast. While oxygen depletion commonly controls the switch from respiration to fermentation, in wild-type S. cerevisiae this switch also occurs in response to the external glucose concentration. The TM6* strain shows a fully respiratory metabolism even at high glucose levels as seen for aerobic organisms due to the characteristics of its chimeric hexose transporter. It therefore switches to fermentation only when oxygen is limiting.
In this study, the effectiveness of the TM6* strain as a microbial cell factory was tested using three challenging membrane protein targets: the eukaryotic glycerol transport facilitator, Fps1 [30, 31] and two recombinant human GPCRs (the A2a adenosine receptor (A2aR) and the cannabinoid receptor 2 (CNR2)); as well as soluble GFP. Our start point was to examine TM6* under conditions that we had previously shown to give maximum recombinant Fps1 yield for the corresponding wild-type  and to compare this with the yield obtained under optimal growth conditions. Therefore TM6* cells were cultured at 20°C, pH 5 and 30°C, pH 5, respectively. Our data show at least a doubling in productivity over wild-type strains for all these proteins when they are produced in TM6* cells. In all cases, this was attributed to the improved biomass properties of the strain. The yield profile across the growth curve was also found to be more stable than in the wild-type strain, and was not further improved by lowering culture temperatures to 20°C, which is commonly found for wild-type strains . This has the added benefit that improved yields can be attained rapidly at the yeast's optimal growth conditions. This improved productivity could not simply be reproduced in a wild-type strain by culturing it under glucose fed-batch conditions prior to glucose exhaustion. Likewise, the productivity of TM6* was unaffected by culturing it in the presence of ethanol.
To conclude, the beneficial properties of TM6* appear to be unique. Consequently, TM6* should prove to be a useful addition to the matrix of production hosts at the disposal of modern structural biology projects, especially for challenging targets such as membrane proteins: we suggest that transfer of expression plasmids from wild-type strains into TM6* is a simple way to at least double the yield of a range of recombinant proteins.
Fps1 can be produced in a range of microbial cell factories
S. cerevisiae W301-1A
S. cerevisiae W301-1A
S. cerevisiae 954 VW K70
 and this study
S. cerevisiae KOY.PK2-1C82
S. cerevisiae TM6*
P. pastoris X-33
P. pastoris X-33
P. pastoris GS115
P. pastoris KM71
E. coli JM109
E. coli JM109
Fps1 can be produced in TM6* at the same yield per unit of total membrane protein as two wild-type strains
Recombinant Fps1 yields per unit of total membrane protein are identical for two wild-type S. cerevisiae strains and respiratory TM6*
Fps1 yield expressed as a mean densitometry signal
954 VW K70
3.3 (0.3; n = 2)
3.2 (0.1; n = 2)
3.5 (0.9; n = 2)
2.6 (0.8; n = 2)
3.7 (0.6; n = 3)
3.7 (0.6; n = 3)
3.7 (0.9; n = 3)
2.5 (0.9; n = 3)
3.1 (0.7; n = 3)
3.2 (0.8; n = 3)
2.4 (0.9; n = 3)
Total volumetric yields of Fps1 from wild-type strains can be more than doubled in TM6* due to its improved biomass yield
Improved Fps1 yields in TM6* cannot be reproduced by culturing wild-type strains under glucose fed-batch conditions prior to glucose exhaustion
Fps1 yields in TM6* are unaffected by growing cultures in the presence of ethanol
Functional yields of two human GPCRs and soluble GFP are also increased when produced in TM6* compared with wild-type S. cerevisiae
Total functional yields from TM6* producing two human GPCRs are at least quadruple that from the corresponding wild-type transformants
Duration of culture (h)
Specific growth rate (h-1)
Dry cell weight yield (g g-1 Glc)
Harvest wet cell weight (g)
Total membrane protein yield (mg)
Bmax (pmol mg-1)
Structural genomics projects have undertaken the important task of characterising the hundreds of proteins that are encoded by organismal genomes. Most recently, membrane-protein-specific consortia have been established such as E-MeP, MePNet, EDICT and others . Typical activities include high-throughput production of large numbers of membrane proteins, especially GPCRs . Such projects are slowly making important contributions to our understanding of the structural biology of membrane proteins (see http://blanco.biomol.uci.edu/Membrane_Proteins_xtal.html), but by their very nature there is a high attrition rate as individual proteins fail to be produced using high-throughput strategies.
A current and very encouraging trend is to consider membrane protein production as a scientific problem that must be systematically and rationally addressed [12–14]. We and others have contributed to this using yeast [21, 22], which has been the production host for a substantial number of recombinant eukaryotic membrane proteins to date. As it is often desirable to obtain structural and functional data on a specific protein, such as a key drug target or an individual member of a biological pathway, this absolutely warrants a systematic, tailored approach. In our own work, we initially focused on the glycerol facilitator from S. cerevisiae - Fps1 - on which we have amassed a body of in vivo structure-activity data [30, 31, 36, 37]. Despite having constructed a good understanding of the gating mechanism of this intriguing protein, the ability to produce it in amounts sufficient for structural studies has remained elusive  (Table 1). In this study we therefore examined production yields in a respiratory S. cerevisiae strain, TM6*, with improved biomass-producing properties .
We found that the best Fps1 yield from previous studies in wild-type yeast  was maintained in the TM6* membrane in cultures grown at 30°C in batch. This is particularly advantageous since the best production conditions are now the optimal growth conditions and hence Fps1 can be produced more quickly in TM6* (generation time 2.9 (SEM: 0.1) h) than in previously-optimised wild-type cultures at 20°C (generation time 8.9 h) . For commercial applications, it is of utmost importance to avoid costs associated with cooling bioreactors and to minimise production times to maximise profit. High-throughput platforms also significantly benefit from shorter generation times. The biggest benefit, however, was the total yield improvement resulting from the improved biomass properties of TM6* compared with the two wild-type strains without the need for complex cultivation regimes. In the glucose phase, maximum yields were achieved in both wild-type strains at an OD610 of 4.5 (0.1) during batch-growth with 2 % glucose in the medium. When we produced Fps1 in the respiratory TM6* strain, however, maximum yields were obtained at an OD610 of 11.0 (1.5), a 2.4-fold increase in biomass over the wild-type. Consequently, the best yields of Fps1 from TM6* were more than 2-fold higher than the best yields from the wild-type strains. Interestingly, yields of Fps1 from TM6* were not further improved by lowering the temperature, in contrast to wild-type strains where this is routinely observed .
We were unable to improve yields of Fps1 in wild-type S. cerevisiae by extending the production phase prior to the diauxic shift (Figure 3) or to reduce yields in TM6* by growing cultures in the presence of ethanol, mimicking conditions found with wild-type yeast (Figure 4). We also found that the ethanol concentration was unchanged through the glucose consumption phase (Figure 4A) which indicated that the TM6* cells grew on glucose without co-consuming substantial amounts of ethanol. As soon as the glucose was depleted, the cells started to grow on the ethanol immediately which is seen by the second CO2 peak and continued biomass accumulation. We therefore concluded that the improved biomass properties of TM6*, which also enhanced the yields of three additional recombinant proteins, could not be achieved through simple manipulation of culture conditions.
In the related respiratory wine strain V5-TM6*P that we have also generated , the genes BIO2, BMS1, MSD1 and RPO41 had a changed expression compared with the V5 parent  and were also correlated with improved protein yields in a wild-type strain . This further strengthens our earlier observations that BMS1 plays a significant role in high yielding recombinant protein production . Interestingly two subunits of the 26S proteosome subunit, RPT1 and RPT2 are also down regulated in V5-TM6*P compared to V5 by a factor of 0.3 . It is thus possible that the respiratory yeast phenotype has less protease activity than a wild-type strain which in turn negates the need to further slow the process by lowering the temperature.
Overall, it is clear that yeast cells are valuable production hosts on account of their potential for high volumetric yields, short generation times and affordable media formulations, especially in comparison with higher eukaryotic systems. Moreover, the ability to engineer strains with desirable properties that minimise stress responses is straightforward in yeast. In the case of an engineered strain such as TM6*, its improved biomass properties, which result from its respiratory phenotype, make it a particularly valuable resource for challenging proteins such as membrane proteins. For example, we report here the first production of functional human CNR2 in S. cerevisiae, and show that we can quadruple its yield by simply switching from a respiro-fermentative to a respiratory strain.
The TM6* phenotype provides a unique opportunity to improve recombinant protein production yields in S. cerevisiae through biomass accumulation. Enhanced volumetric yields were achieved for the yeast glycerol facilitator, Fps1, the human GPCRs, A2aR and CNR2, and a soluble GFP. The TM6* respiratory strain should therefore prove to be a useful addition to the matrix of production hosts at the disposal of modern structural biology projects, especially for challenging proteins.
The FPS1 gene was tagged at its 3' end with a sequence encoding the HA3 epitope to permit immunodetection; the carboxy-terminal threonine residue was replaced with the amino acid sequence: SGRIFYPYDVPDYA GYPYDVPDYA GYPYDVPDYA AQCGR. The HA3-tag sequence is underlined. The construct was expressed from the TPI promoter in the 2 μ pYX212 vector (Novagen; now discontinued) which contains the URA3 selection marker. The gene was cloned into the Bam H1 and Hin dIII sites and the vector transformed into S. cerevisiae TM6*, KOY.PK2-1C82 and BY4741. For the S. cerevisiae 954 VW K70 strain the construct was expressed from the TPI promoter in the 2 μ pYX222 vector (Novagen; now discontinued), which contains the HIS3 selection marker. Genes encoding human A2aR and CNR2 receptors were tagged as above at the 3' end with the HA3-tag and at the 5' end with a sequence encoding the S. cerevisiae α factor secretion signal: MRFPSIFTAVLFAASSALAAPVNTTTEDETAQIPAEAVIGYSDLEGDFDVAVLPFSNSTNNGLLFINTTIASIAAKEEGVSLEKREAGS. The constructs were expressed from the TPI promoter in both the pYX212 and pYX222 vectors. The pCU426 GFP construct was the generous gift of Dr Arle Kruckeberg.
Yeast strains and growth conditions
The constructs cloned into plasmids pYX212 and pCU426 were transformed into S. cerevisiae strains KOY-TM6*, referred to as TM6* , KOY.PK2-1C82 (MATa, ura 3-52, MAL 2-8 c SUC2)  and BY4741 (MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0). Constructs cloned into plasmid pYX222 were transformed into S. cerevisiae strain 954 VW K70 (MATα his3 SUC2 GAL MAL 2-8 c ). Yeast transformants were initially grown on YNB agar plates lacking uracil or histidine to select for plasmid retention. For the TM6* Fps1 cultivations, 5 mL cultures were inoculated and grown for 72 h prior to being used to inoculate 50 mL cultures, which were grown for a period of 24 h and used to inoculate cultures in 2.5 L to a final OD610 of 0.05. For the wild-type cultivations, 100 mL cultures were grown for 24 h before inoculating the bioreactors to a final OD610 of 0.05. Yeast cells were cultured in 2.5 L 2 × CBS medium , with 2 % glucose as the sole carbon and energy source. For growth of TM6* with ethanol in the medium, 7 g L-1 ethanol were added to the bioreactor together with glucose just before the inoculation. The pH of the cultures was maintained at pH 5 using 1 M NaOH. Polypropylene glycol P2000 was added as antifoam (100 μL L-1). Agitation and aeration of the cultures were set at 1000 rpm and 0.5 vol vol-1 min-1, respectively whilst the temperature was set at either 20°C or 30°C. The control of the pH, agitation, aeration and temperature was maintained online. Gas evolution was monitored on-line (type CP460 O2/CO2, Belach Bioteknik AB).
For glucose fed-batch cultivations, the wild-type S. cerevisiae strain 954 VW K70 was cultured at 30°C, pH 5. 100 mL cultures were grown for a period of 24 h and used to inoculate cultures in 2.5 L bioreactors to a final OD610 of 0.1. Yeast cells were cultured in 2.0 L YNB medium (1.7 g L-1 YNB (Q-Biogene), 5 g L-1 (NH4)2SO4) with 1 % glucose until glucose was depleted, and then grown with a feed of 500 mL 10 % glucose at a flow rate of 20 mL h-1. Polypropylene glycol P2000 was added as antifoam (100 μL L-1). Agitation of the cultures was set at 600 rpm and airflow of 0.6 L min-1. All cultivations were at least duplicated. We have previously developed a series of simple functional in vivo assays for aquaporins in yeast  (and references therein), and hence were able to confirm that the Fps1 was active under these conditions. Fps1 activity in wild-type yeast was previously reported , and there were no indications of any differences in this study.
BY4741 or TM6* transformed with the GPCR constructs were initially grown on YNB plates lacking uracil to verify plasmid retention. Single colonies were then used to inoculate 50 mL 2 × CBS medium and cultured for a period of 24-48 h. These pre-cultures were then used to inoculate 500 mL 2 × CBS medium in a bioreactor to a final OD610 nm of 0.05 and cultured until glucose depletion was detected using a Accu-Chek active glucose analyser (Roche diagnostics, UK) according to the manufacturer's instructions. Cells were harvested by centrifugation at 5, 000 × g, 4°C, 5 min.
BY4741 or TM6* transformed with the GFP construct were grown on YNB plates lacking uracil to verify plasmid retention. Single colonies were then used to inoculate 50 mL YNB medium and cultured for a period of 48 h. These seed cultures were then used to inoculate fresh 50 mL YNB medium in shake-flasks containing 0 or 1 mM CuSO4 to a final OD610 of 0.15 and cultured for a period of 24 h. Cells were harvested by centrifugation at 5, 000 × g, 4°C, 5 min.
Protein, cell dry weight and extracellular substrate determination
Samples for optical density measurements were taken periodically to measure growth. For the wild-types and ethanol-phase TM6* cultures, additional samples for subsequent protein, dry weight, and extracellular substrate/product analysis were taken out at early, mid and late glucose phase (1-3-Glc) corresponding to a glucose concentration of 1.5 %, 1.0 % and 0.8 % respectively, 4-Glc (when the glucose is depleted), and 5-EtOH and 6-Stat during the ethanol and stationary phases, 6.5 h, and 18.5 h after glucose depletion, respectively. The same procedure was performed for the TM6* cultures but also at additional time points. Therefore Glc 1-3 correspond to glucose concentrations above 1.5 %, 1.5-0.5 % and below 0.5 %, respectively. 4-Glc corresponds to glucose exhaustion and the stationary phase samples, 5-Stat, for the TM6* cultures are samples taken at least 10 h after glucose exhaustion. For extracellular substrate analysis, samples (2 × 1 mL) were collected, and the supernatant recovered by centrifugation (13, 000 × g for 1 min) and stored at -20°C prior to analysis with Boehringer Mannheim GmbH kits (Food Diagnostics, Stenungsund, Sweden) according to the manufacturer's instructions. Dry weight calculations were performed by harvesting 2 × 5 mL samples in pre-weighed, desiccated sample vials, and the cell pellet recovered by centrifugation at 5,000 × g for 5 min, at 4°C. The cells were subsequently washed twice with 5 mL ice-cold MilliQ water, and recovered by centrifugation, as above. The pellets were then dried for 24 h at 110°C, and stored in a desiccator prior to being weighed. Samples for protein analysis (1-4 × 50 mL) were harvested and the cell pellet recovered by centrifugation at 5,000 × g for 5 min at 4°C and stored at -20°C.
Membrane preparation and immunoblots
Analysis of Fps1 protein yields were performed on both the total cellular extract and the total membrane fraction. Cells were suspended in 20 mM Tris-HCl (pH 7.6), 100 mM NaCl, 0.5 mM EDTA, 5 % glycerol and mixed with glass beads at a 1:1:1 ratio. The cells were agitated in a FastPrep (Q-Biogene) at a speed of 6.5, 3 × 20 s with a 60 s incubation on ice between the pulses. Unbroken cells were recovered by centrifugation at 500 × g for 10 min at 4°C, and the supernatant further clarified at 10,000 × g for 30 min at 4°C. The total membrane fraction was collected from this clarified supernatant by ultra-centrifugation at 100,000 × g for 90 min at 4°C. The protein concentration was estimated using a BioRad Protein Assay Kit with bovine serum albumin as a standard. Immunoblotting was carried out with 35 μg of crude cell extract and 75 μg of total membrane fraction loaded on a 7.5 % SDS polyacrylamide gel and separated at 65 V through the stacking gel and 140 V through the separating gel for approximately 1 h. Proteins were transferred to a nitrocellulose membrane and blocked with PBS containing 5 % milk for 1 h before being probed with a mouse monoclonal HA antibody (1:1,000) overnight in PBS containing 5 % milk. After washing with PBS containing 5 % milk the membrane was incubated with a secondary goat anti-mouse IgG HRP conjugated antibody (1:2,500) for 1 h in PBS containing 5 % milk. The membrane was then washed in PBS containing 5 % milk; followed by PBS containing 0.1 % Tween-20 and finally with PBS. The blots were developed with an ECL Plus Western Blotting Detection Kit (Amersham Pharmacia) according to the manufacturer's instructions, visualised using the Image Reader LAS-100 (Fujifilm), and quantified using Multi Gauge 3.0 (Fujifilm). Either total extract or the membrane-bound fraction isolated from Sample 2 of a 30°C, pH 5 wild-type culture  in YNB medium was used as an internal standard, which is the yield of Fps1 during the glucose growth phase of cells cultured at 30°C, pH 5 when the OD610 was 1.5-3.0 and residual glucose levels were 2-5 g/L. All signals were below saturation and related to the signal of the internal standard.
Radioligand binding on wild-type and TM6* membranes containing recombinant human A2aR and CNR2
Cells were washed once with ice-cold breaking buffer (50 mM sodium phosphate buffer pH7.4, 100 mM NaCl, 5 % glycerol, 2 mM EDTA, 1 mM PMSF) and suspended to 30 % wet weight. 0.5 mm glass beads were added to the cell suspension at a 1:1 ratio and cells broken at 4°C using a FastPrep24 cell disrupter (MP Biomedical) with 8 cycles of 30 s shaking and 30 s incubation on ice. Unbroken cells/cell debris were separated from the membrane suspension by centrifugation (3000 × g, 5 min, 4°C). Total membranes were then recovered at 100,000 × g, 45 min, 4°C and suspended in membrane buffer (50 mM Tris pH 8.0, 120 mM NaCl, 20 % glycerol, 1 mM PMSF) using a dounce homogenizer. Membrane proteins were quantified following the BCA method (Pierce, Rockford, IL, USA), using BSA as a standard and snap frozen in liquid nitrogen prior to storage at - 80°C.
Saturation ligand binding assays were performed for membranes containing human A2aR with [3H]ZM241385 and ZM241385 (10 μM) ligands in 50 mM Tris HCl pH 7.4, 1 mM EDTA, 10 mM MgCl2, and incubated at 25°C for 1 h. In the case of human CNR2, [3H]CP55940 and CP55940 (50 μM) in 50 mM Tris HCl pH 7.4, 2.5 mM EDTA, 5 mM MgCl2, 0.5 mg ml-1 BSA were incubated at 30°C for 1.5 h. For each experiment, 10 μg of membrane protein were incubated in triplicate with increasing concentrations of radioligand until equilibrium was reached (total binding conditions). For non-specific binding determination, similar incubations were performed in parallel in the presence of an excess of unlabelled specific ligand. Bound and free ligands were separated by rapid filtration with Perkin-Elmer GF/B 96-unifilters pre-soaked in 0.3 % polyethylenimine. The filters were washed 3 times and the retained radioactivity measured by liquid scintillation counting in a TopCount scintillation counter (Perkin Elmer). Saturation curves were analysed by nonlinear regression using Prism software (GraphPad Software, La Jolla, USA) to determine Bmax and Kd values.
GFP determination in wild-type and TM6* strains
Cells were suspended in 0.7 mL ice-cold breaking buffer (50 mM sodium phosphate buffer pH7.4, 100 mM NaCl, 5 % glycerol, 2 mM EDTA) and glass beads added at a 1:1 ratio. Cells were disrupted in a FastPrep24 for 4 cycles of speed 6.5, 30 s with 2 min incubation on ice between cycles. Cell debris and unbroken cells were removed by centrifugation at 5,000 × g, 4°C for 3 min and the supernatant clarified and recovered at 20,000 × g, 4°C for 30 min. 150 μl of supernatant was mixed with 50 μL 1 M potassium phosphate, pH 8.0 and loaded in triplicate in black Nunc MaxiSorp 96-well plates. The fluorescence was determined on a SpectraMax Gemini XS plate reader (Molecular Devices, Wokingham, UK) with excitation and emission wavelengths of 390 nm and 510 nm respectively and a 495 nm cut-off.
This work was supported by the European Commission via contracts LSHG-CT-2004-504601 (E-MeP) and LSHG-CT-2006-037793 (OptiCryst) to RMB, and QLG2-CT-2002-00988 (SPINE) to LG and RMB. The BBSRC supports bioreactors and a flow microcalorimeter in the RMB Laboratory through an REI award.
- Grisshammer R, Tate C: Overexpression of integral membrane proteins for structural studies. Q Rev Biophys. 1995, 3: 315-422. 10.1017/S0033583500003504.View Article
- Miroux B, Walker JE: Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J Mol Biol. 1996, 260 (3): 289-298. 10.1006/jmbi.1996.0399.View Article
- Ward A, Sanderson NM, O'Reilly J, Rutherford NG, Poolman B, Henderson PJF: Membrane Transport, a practical approach. Edited by: Baldwin SA. 2000, 141-166. New York: Oxford University Press
- Monne M, Chan KW, Slotboom DJ, Kunji ER: Functional expression of eukaryotic membrane proteins in Lactococcus lactis. Protein Sci. 2005, 14 (12): 3048-3056. 10.1110/ps.051689905.View Article
- Wagner S, Klepsch MM, Schlegel S, Appel A, Draheim R, Tarry M, Hogbom M, van Wijk KJ, Slotboom DJ, Persson JO, et al.: Tuning Escherichia coli for membrane protein overexpression. Proc Natl Acad Sci USA. 2008, 105 (38): 14371-14376. 10.1073/pnas.0804090105.View Article
- Bill RM: Yeast-a panacea for the structure-function analysis of membrane proteins?. Curr Genet. 2001, 40 (3): 157-171. 10.1007/s002940100252.View Article
- Bosman GJ, van Oostrum J, Breikers G, Bovee-Geurts PH, Klaassen CH, DeGrip WJ: Functional expression of His-tagged rhodopsin in Sf9 insect cells. Methods Mol Biol. 2003, 228: 73-86.
- Lundstrom K: Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochim Biophys Acta. 2003, 1610 (1): 90-96. 10.1016/S0005-2736(02)00721-6.View Article
- Koglin A, Klammt C, Trbovic N, Schwarz D, Schneider B, Schafer B, Lohr F, Bernhard F, Dotsch V: Combination of cell-free expression and NMR spectroscopy as a new approach for structural investigation of membrane proteins. Magn Reson Chem. 2006, 44 (S1): 17-23. 10.1002/mrc.1833.View Article
- Heterologous Expression of Membrane Proteins: Methods and Protocols. Edited by: Mus-Veteau I. 2010, New York: Humana Press
- Sarramegna V, Talmont F, Demange P, Milon A: Heterologous expression of G-protein-coupled receptors: comparison of expression systems from the standpoint of large-scale production and purification. Cell Mol Life Sci. 2003, 60 (8): 1529-1546. 10.1007/s00018-003-3168-7.View Article
- Freigassner M, Pichler H, Glieder A: Tuning microbial hosts for membrane protein production. Microb Cell Fact. 2009, 8: 69- 10.1186/1475-2859-8-69.View Article
- Grisshammer R: Understanding recombinant expression of membrane proteins. Curr Opin Biotechnol. 2006, 17 (4): 337-340. 10.1016/j.copbio.2006.06.001.View Article
- Wagner S, Bader ML, Drew D, de Gier JW: Rationalizing membrane protein overexpression. Trends Biotechnol. 2006, 24 (8): 364-371. 10.1016/j.tibtech.2006.06.008.View Article
- Reilander H, Weiss HM: Production of G-protein-coupled receptors in yeast. Curr Opin Biotechnol. 1998, 9 (5): 510-517. 10.1016/S0958-1669(98)80038-4.View Article
- Gelperin DM, White MA, Wilkinson ML, Kon Y, Kung LA, Wise KJ, Lopez-Hoyo N, Jiang L, Piccirillo S, Yu H, et al.: Biochemical and genetic analysis of the yeast proteome with a movable ORF collection. Genes Dev. 2005, 19 (23): 2816-2826. 10.1101/gad.1362105.View Article
- Jidenko M, Nielsen RC, Sorensen TL, Moller JV, le Maire M, Nissen P, Jaxel C: Crystallization of a mammalian membrane protein overexpressed in Saccharomyces cerevisiae. Proc Natl Acad Sci USA. 2005, 102 (33): 11687-11691. 10.1073/pnas.0503986102.View Article
- Long SB, Campbell EB, Mackinnon R: Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science. 2005, 309 (5736): 897-903. 10.1126/science.1116269.View Article
- Tornroth-Horsefield S, Wang Y, Hedfalk K, Johanson U, Karlsson M, Tajkhorshid E, Neutze R, Kjellbom P: Structural mechanism of plant aquaporin gating. Nature. 2006, 439 (7077): 688-694. 10.1038/nature04316.View Article
- Horsefield R, Norden K, Fellert M, Backmark A, Tornroth-Horsefield S, Terwisscha van Scheltinga AC, Kvassman J, Kjellbom P, Johanson U, Neutze R: High-resolution x-ray structure of human aquaporin 5. Proc Natl Acad Sci USA. 2008, 105 (36): 13327-13332. 10.1073/pnas.0801466105.View Article
- Bonander N, Hedfalk K, Larsson C, Mostad P, Chang C, Gustafsson L, Bill RM: Design of improved membrane protein production experiments: quantitation of the host response. Protein Sci. 2005, 14 (7): 1729-1740. 10.1110/ps.051435705.View Article
- Griffith DA, Delipala C, Leadsham J, Jarvis SM, Oesterhelt D: A novel yeast expression system for the overproduction of quality-controlled membrane proteins. FEBS Lett. 2003, 553 (1-2): 45-50. 10.1016/S0014-5793(03)00952-9.View Article
- Bonander N, Darby RA, Grgic L, Bora N, Wen J, Brogna S, Poyner DR, O'Neill MA, Bill RM: Altering the ribosomal subunit ratio in yeast maximizes recombinant protein yield. Microb Cell Fact. 2009, 8: 10- 10.1186/1475-2859-8-10.View Article
- Cereghino JL, Cregg JM: Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev. 2000, 24 (1): 45-66. 10.1111/j.1574-6976.2000.tb00532.x.View Article
- Holmes WJ, Darby RA, Wilks MD, Smith R, Bill RM: Developing a scalable model of recombinant protein yield from Pichia pastoris: the influence of culture conditions, biomass and induction regime. Microb Cell Fact. 2009, 8: 35- 10.1186/1475-2859-8-35.View Article
- Singh S, Gras A, Fiez-Vandal C, Ruprecht J, Rana R, Martinez M, Strange PG, Wagner R, Byrne B: Large-scale functional expression of WT and truncated human adenosine A2A receptor in Pichia pastoris bioreactor cultures. Microb Cell Fact. 2008, 7: 28- 10.1186/1475-2859-7-28.View Article
- Mattanovich D, Gasser B, Hohenblum H, Sauer M: Stress in recombinant protein producing yeasts. J Biotechnol. 2004, 113 (1-3): 121-135. 10.1016/j.jbiotec.2004.04.035.View Article
- Bill RM, Boles E, Gustafsson L, Hohmann S, Larsson C, Otterstedt K: Recombinant Saccharomyces cerevisiae Expressing Chimeric Glucose Transporters. WO0200880. 2002
- Otterstedt K, Larsson C, Bill RM, Stahlberg A, Boles E, Hohmann S, Gustafsson L: Switching the mode of metabolism in the yeast Saccharomyces cerevisiae. EMBO Rep. 2004, 5 (5): 532-537. 10.1038/sj.embor.7400132.View Article
- Tamas MJ, Karlgren S, Bill RM, Hedfalk K, Allegri L, Ferreira M, Thevelein JM, Rydstrom J, Mullins JG, Hohmann S: A short regulatory domain restricts glycerol transport through yeast Fps1p. J Biol Chem. 2003, 278 (8): 6337-6345. 10.1074/jbc.M209792200.View Article
- Hedfalk K, Bill RM, Mullins JG, Karlgren S, Filipsson C, Bergstrom J, Tamas MJ, Rydstrom J, Hohmann S: A regulatory domain in the C-terminal extension of the yeast glycerol channel Fps1p. J Biol Chem. 2004, 279 (15): 14954-14960. 10.1074/jbc.M313126200.View Article
- Cassland P, Jonsson LJ: Characterization of a gene encoding Trametes versicolor laccase A and improved heterologous expression in Saccharomyces cerevisiae by decreased cultivation temperature. Appl Microbiol Biotechnol. 1999, 52 (3): 393-400. 10.1007/s002530051537.View Article
- Sorensen HP, Mortensen KK: Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact. 2005, 4 (1): 1- 10.1186/1475-2859-4-1.View Article
- Lundstrom K: Structural genomics on membrane proteins: mini review. Comb Chem High Throughput Screen. 2004, 7 (5): 431-439.View Article
- Andre N, Cherouati N, Prual C, Steffan T, Zeder-Lutz G, Magnin T, Pattus F, Michel H, Wagner R, Reinhart C: Enhancing functional production of G protein-coupled receptors in Pichia pastoris to levels required for structural studies via a single expression screen. Protein Sci. 2006, 15 (5): 1115-1126. 10.1110/ps.062098206.View Article
- Bill RM, Hedfalk K, Karlgren S, Mullins JG, Rydström J, Hohmann S: Analysis of the pore of the unusual major intrinsic protein channel, yeast Fps1p. J Biol Chem. 2001, 276 (39): 36543-36549. 10.1074/jbc.M105045200.View Article
- Karlgren S, Filipsson C, Mullins JG, Bill RM, Tamas MJ, Hohmann S: Identification of residues controlling transport through the yeast aquaglyceroporin Fps1 using a genetic screen. Eur J Biochem. 2004, 271 (4): 771-779. 10.1111/j.1432-1033.2004.03980.x.View Article
- Hedfalk K, Bill RM, Hohmann S, Rydström J: Overexpression and purification of the glycerol transport facilitators, Fps1p and GlpF in S. cerevisiae and E. coli. Molecular Biology and Physiology of Water and Solute Transport: the MIP Family of Channel Proteins. Edited by: Hohmann S, Nielsen S. 2000, p29-34. New York: Kluwer/PlenumView Article
- Henricsson C, de Jesus Ferreira MC, Hedfalk K, Elbing K, Larsson C, Bill RM, Norbeck J, Hohmann S, Gustafsson L: Engineering of a novel Saccharomyces cerevisiae wine strain with a respiratory phenotype at high external glucose concentrations. Appl Environ Microbiol. 2005, 71 (10): 6185-6192. 10.1128/AEM.71.10.6185-6192.2005.View Article
- Bonander N, Ferndahl C, Mostad P, Wilks MD, Chang C, Showe L, Gustafsson L, Larsson C, Bill RM: Transcriptome analysis of a respiratory Saccharomyces cerevisiae strain suggests the expression of its phenotype is glucose insensitive and predominantly controlled by Hap4, Cat8 and Mig1. BMC Genomics. 2008, 9: 365- 10.1186/1471-2164-9-365.View Article
- Bonander N, Bill RM: Relieving the first bottleneck in the drug discovery pipeline: using array technologies to rationalise membrane protein production. Expert Rev Proteomics. 2009, 6: 501-505. 10.1586/epr.09.65.View Article
- Elbing K, Stahlberg A, Hohmann S, Gustafsson L: Transcriptional responses to glucose at different glycolytic rates in Saccharomyces cerevisiae. Eur J Biochem. 2004, 271 (23-24): 4855-4864. 10.1111/j.1432-1033.2004.04451.x.View Article
- Dijken JPv, Bauer J, Brambilla L, Duboc P, Francois JM, Gancedo C, Giuseppin MLF, Heijnen JJ, Hoare M, Lange HC, et al.: An interlaboratory comparison of physiological and genetic properties of four Saccharomyces cerevisiae strains. Enz Microb Technol. 2000, 26: 706-714. 10.1016/S0141-0229(00)00162-9.View Article
- Verduyn C, Postma E, Scheffers WA, Van Dijken JP: Effect of benzoic acid on metabolic fluxes in yeasts: a continuous-culture study on the regulation of respiration and alcoholic fermentation. Yeast. 1992, 8 (7): 501-517. 10.1002/yea.320080703.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.